Praziquantel in the cerebrospinal fluid in neurocysticercosis
In 10 patients with neurocysticercosis (NC), an assessment was made of the praziquantel (PZQ) concentration in the cerebrospinal fluid (CSF), in non-deproteinized serum and in protein-free serum: before administration of the drug and the 1st., 7th. and 21st. days of oral administration (50mg/kg/day...
Main Authors: | A. Spina-França, L. R. Machado, J. P. S. Nobrega, J. A. Livramento, H. W. Diekmann, E. Groll, G. L. de Rezende |
---|---|
Format: | Article |
Language: | English |
Published: |
Academia Brasileira de Neurologia (ABNEURO)
1985-09-01
|
Series: | Arquivos de Neuro-Psiquiatria |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X1985000300003&lng=en&tlng=en |
Similar Items
-
Neurocisticercose e praziquantel: evolução a longo prazo de 100 pacientes
by: A. Spina-França, et al.
Published: (1989-12-01) -
Use of praziquantel in populations at risk of neurocysticercosis
by: Jaime R. Torres R.
Published: (1989-08-01) -
Serum and cerebrospinal fluid S100B concentrations in patients with neurocysticercosis
by: J.E. Lima, et al.
Published: (2006-01-01) -
Total IgE detection in paired cerebrospinal fluid and serum samples from patients with neurocysticercosis
by: Ednéia Casagranda BUENO, et al.
Published: (2000-04-01) -
Cysticercosis of the central nervous system and cerebrospinal fluid immunodiagnosis of 1573 patients in 63 years (1929-1992)
by: A. Spina-França, et al.
Published: (1993-03-01)